Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Account Payables (2016 - 2025)

Conmed (CNMD) has disclosed Change in Account Payables for 16 consecutive years, with -$13.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 2053.8% year-over-year to -$13.6 million, compared with a TTM value of -$9.7 million through Dec 2025, down 166.26%, and an annual FY2025 reading of -$9.7 million, down 166.26% over the prior year.
  • Change in Account Payables was -$13.6 million for Q4 2025 at Conmed, down from $5.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $13.0 million in Q1 2024 and bottomed at -$13.6 million in Q4 2025.
  • Average Change in Account Payables over 5 years is $1.9 million, with a median of $2.4 million recorded in 2023.
  • The sharpest move saw Change in Account Payables surged 1858.37% in 2022, then tumbled 2053.8% in 2025.
  • Year by year, Change in Account Payables stood at $11.1 million in 2021, then tumbled by 110.56% to -$1.2 million in 2022, then surged by 672.55% to $6.7 million in 2023, then crashed by 109.41% to -$632000.0 in 2024, then crashed by 2053.8% to -$13.6 million in 2025.
  • Business Quant data shows Change in Account Payables for CNMD at -$13.6 million in Q4 2025, $5.5 million in Q3 2025, and $5.7 million in Q2 2025.